Related Experiment Videos
Proinflammatory cytokines in cardiac myxomas
C J Wiedermann1, N Reinisch, R Fischer-Colbrie
1Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Austria.
Journal of Internal Medicine
|September 1, 1992
Summary
Interleukin-6 (IL-6) levels correlate with immunological issues in cardiac myxoma patients. Atrial natriuretic peptide reflects hemodynamic changes, not the tumor itself.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Cardiac myxomas can present with constitutional and immunological symptoms.
- The role of specific cytokines in these presentations is not fully understood.
Purpose of the Study:
- To investigate the relationship between serum cytokine levels and clinical/immunological features in cardiac myxoma patients.
- To assess the correlation of atrial natriuretic peptide with hemodynamic status.
Main Methods:
- Serum samples from three cardiac myxoma patients were analyzed.
- Levels of interleukin-6 (IL-6), IL-1, TNF-alpha, and IFN-gamma were measured.
- Atrial natriuretic peptide levels were also assessed.
Main Results:
- Elevated IL-6 levels were observed in patients with constitutional symptoms and immunological features.
- IL-6, but not other measured cytokines, correlated with immunological markers.
- Atrial natriuretic peptide levels correlated with hemodynamic changes, independent of tumor presence.
Conclusions:
- IL-6 is a potential biomarker for immunological manifestations in cardiac myxomas.
- Atrial natriuretic peptide serves as an indicator of hemodynamic compromise in these patients.